Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral bacterial cell membrane and cell envelope represent a complex structural barrier essential for the survival and pathogenicity of microbes within the oral cavity (StatPearls, 2023). In Gram-positive bacteria, such as Streptococcus mutans, the envelope consists of a thick peptidoglycan layer, while Gram-negative species like Porphyromonas gingivalis possess an additional outer membrane containing lipopolysaccharides (LPS) (PubMed, PMID: 30257461). These structures provide mechanical support, regulate the transport of nutrients and waste, and facilitate adhesion to dental surfaces and host tissues (NIH, 2022). Therapeutic agents like chlorhexidine and cetylpyridinium chloride target these components by disrupting membrane stability or inhibiting cell wall synthesis, which is critical for controlling dental plaque and preventing periodontal diseases (Journal of Oral Microbiology, 2021). Furthermore, the cell envelope serves as a primary interface for host-pathogen interactions, often triggering inflammatory responses that lead to tissue destruction in periodontitis (Nature Reviews Microbiology, 2018). Disruption of these components leads to increased permeability, leakage of intracellular ions, and eventual cell death (PubChem). However, the broad-spectrum nature of these treatments can lead to concerns regarding the disruption of the commensal oral microbiome and the development of bacterial resistance (Nature Reviews Microbiology, 2018).
Disruption of membrane integrity, inhibition of peptidoglycan synthesis, and alteration of membrane permeability leading to cell lysis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral bacterial cell membranes and cell envelope components.